Thus, we hypothesize that the increase observed in anti-spike IgA levels in baseline-seropositive individuals following AZD1222 vaccination is dimeric IgA secreted from existing NALT-resident B cells induced from prior natural infection, as seen previously with mRNA and other adenovirus-based vaccines.34 The gene discussed is CD79A; the disease is infection.